Track the market's highs and lows with our comprehensive view of top gainers and top losers in stocks. Get key insights at a glance!
Top Gainers
Glenmark Life
Pharmaceuticals
26 Apr 2024
Zensar Tech.
IT - Software
26 Apr 2024
New India Assur...
Insurance
26 Apr 2024
Westlife Food
Quick Service R...
26 Apr 2024
Tech Mahindra
IT - Software
26 Apr 2024
Top Losers
L&T Technology
IT - Software
26 Apr 2024
Hitachi Energy
Capital Goods -...
26 Apr 2024
Offer Related Information Initial public offering of 40,058,844 equity shares of face value of Re. 1 each ("Equity Shares") of Mankind Pharma Limited ("The Company" or the "Issuer") for cash at a price of Rs. [*] per equity share ("Offer Price") aggregating to Rs. [*] crores, comprising an offer for sale of up to 3,705,443 equity shares aggregating to Rs. [*] crores by Ramesh Juneja, up to 3,505,149 equity shares aggregating to Rs. [*] crores by Rajeev Juneja, up to 2,804,119 equity shares aggregating to Rs. [*] crores by Sheetal Arora (collectively, the "Promoter Selling Shareholders"), up to 17,405,559 equity shares aggregating to Rs. [*] crores by Cairnhill Cipef Limited, up to 2,623,863 equity shares aggregating to Rs. [*] crores by Cairnhill Cgpe Limited, up to 9,964,711 equity shares aggregating to Rs. [*] crores by Beige Limited and up to 50,000 equity shares aggregating to Rs. [*] crores by Link Investment Trust (collectively, the "Investor Selling Shareholders") (the "Promoter Selling Shareholders" and the "Investor Selling Shareholders", together, the "Selling Shareholders") (the "Offer for Sale" or the "Offer"). The offer shall constitute [*]% of the post-offer paid-up equity share capital of the company. Price Band: Rs. 1026 to Rs. 1080 per equity share of the face value of Re. 1 each. The Floor price is 1026 times and the cap price is 1080 times the face value of the equity shares. Bids can be made for a minimum of 13 equity shares and in multiples of 13 equity shares thereafter.Offer Related Information Initial public offering of 40,058,844 equity shares of face value of Re. 1 each ("Equity Shares") of Mankind Pharma Limited ("The Company" or the "Issuer") for cash at a price of Rs. [*] per equity share ("Offer Price") aggregating to Rs. [*] crores, comprising an offer for sale of up to 3,705,443 equity shares aggregating to Rs. [*] crores by Ramesh Juneja, up to 3,505,149 equity shares aggregating to Rs. [*] crores by Rajeev Juneja, up to 2,804,119 equity shares aggregating to Rs. [*] crores by Sheetal Arora (collectively, the "Promoter Selling Shareholders"), up to 17,405,559 equity shares aggregating to Rs. [*] crores by Cairnhill Cipef Limited, up to 2,623,863 equity shares aggregating to Rs. [*] crores by Cairnhill Cgpe Limited, up to 9,964,711 equity shares aggregating to Rs. [*] crores by Beige Limited and up to 50,000 equity shares aggregating to Rs. [*] crores by Link Investment Trust (collectively, the "Investor Selling Shareholders") (the "Promoter Selling Shareholders" and the "Investor Selling Shareholders", together, the "Selling Shareholders") (the "Offer for Sale" or the "Offer"). The offer shall constitute [*]% of the post-offer paid-up equity share capital of the company. Price Band: Rs. 1026 to Rs. 1080 per equity share of the face value of Re. 1 each. The Floor price is 1026 times and the cap price is 1080 times the face value of the equity shares. Bids can be made for a minimum of 13 equity shares and in multiples of 13 equity shares thereafter.